https://sites.bvsalud.org/pie/biblio?q=&filter=indexed_database%3A%22PIE%22+AND+indexed_database%3A%22PIE%22 Thu, 12 Mar 2026 19:45:49 UTC https://sites.bvsalud.org/pie/biblio/resource/?id=biblioref.referencesource.1647473
Las directrices, los informes de evaluación de tecnologías sanitarias, las solicitudes de inclusión en la lista de medicamentos esenciales y las sinopsis de evidencia para la formulación de políticas están diseñados para brindar apoyo en la toma de decisiones sobre intervenciones en materia de salud, y se conocen colectivamente como “productos de evidencia”. Estos productos tienen muchos elementos similares, como el análisis de la relación entre los beneficios (eficacia, efectividad) y los daños (seguridad, efectos adversos), la utilización de las revisiones sistemáticas como fuente de evidencia y el uso de un marco PICO (población, intervención, comparador y resultado) u otro formato similar para estructurar las preguntas sobre las intervenciones. Además, cuentan con procesos para incluir las aportaciones de las partes interesadas, evaluar y gestionar los conflictos de intereses, y velar por la transparencia. Por lo tanto, podrían lograrse sinergias si hubiera uniformidad entre los componentes esenciales de presentación de información en los distintos tipos de productos. Esta publicación incluye una lista de 26 componentes esenciales diseñados para guiar la presentación de información en las directrices, evaluaciones de tecnologías sanitarias, solicitudes de inclusión en la lista de medicamentos esenciales y sinopsis de evidencia para la formulación de políticas. El público destinatario de esta orientación es el personal de la Organización Mundial de la Salud y la Organización Panamericana de la Salud y sus Estados Miembros, los centros colaboradores y otras organizaciones asociadas que encargan, elaboran o revisan informes sobre productos de evidencia. Esta lista puede utilizarse cuando se crean nuevas plantillas o se actualizan las existentes para cada producto de evidencia. Será útil para los países (y otros usuarios) que deseen mejorar la calidad y la exhaustividad de sus informes sobre productos de evidencia. También puede ayudarles a lograr mayor eficiencia en su elaboración, uso y adaptación, al permitir la reutilización de la información (con actualizaciones o adaptaciones cuando sea pertinente). Esta lista fue diseñada para complementar los documentos de orientación metodológica y de presentación de información existentes para cada uno de los productos de evidencia, que brindan información más específica sobre las mejores prácticas para su producción.

As diretrizes, os relatórios de avaliação de tecnologias em saúde, os pedidos de inclusão na lista de medicamentos essenciais e as sínteses de evidências para políticas são documentos elaborados para apoiar a tomada de decisão sobre intervenções em saúde, coletivamente conhecidos como produtos de evidências. Esses produtos possuem muitos elementos semelhantes. Por exemplo, todos incluem uma análise do balanço entre os benefícios (eficácia, efetividade) e os danos (segurança, efeitos adversos), todos usam revisões sistemáticas como fonte de evidências e todos usam a estrutura PICO (população, intervenção, comparação, resultados) ou outra estrutura similar para estruturar perguntas sobre intervenções. Além disso, todos contam com processos para incluir contribuições das partes interessadas, avaliar e gerenciar conflitos de interesse e assegurar a transparência. Dessa forma, seria possível obter sinergias se houvesse uniformidade nos componentes essenciais para a apresentação de informações nos diferentes tipos de produtos. Esta publicação inclui uma lista de 26 componentes essenciais concebidos para guiar a apresentação de informações em diretrizes, avaliações de tecnologias em saúde, pedidos de inclusão na lista de medicamentos essenciais e sínteses de evidências para políticas. Essas orientações se destinam aos funcionários da Organização Mundial da Saúde e da Organização Pan-Americana da Saúde e seus Estados Membros, centros colaboradores e outras organizações parceiras que encomendam, elaboram ou revisam produtos de evidências. A lista pode ser utilizada para desenvolver novos modelos de apresentação de informações ou atualizar modelos existentes para cada um dos produtos de evidências. Ela será útil para os países (e para outros usuários) melhorarem a qualidade e a completude dos relatórios de seus produtos de evidências. Além disso, a lista pode ajudá-los a aumentar a eficiência na elaboração, no uso e na adaptação desses produtos ao permitir a reutilização de informações (com atualizações ou adaptações, se for o caso). A lista foi elaborada para complementar documentos de orientação metodológica e guias de apresentação de informações existentes para cada um dos produtos de evidências, que fornecem informações mais específicas sobre as melhores práticas para sua elaboração.]]> 1647473 Fri, 20 Feb 2026 00:00:00 UTC https://sites.bvsalud.org/pie/biblio/resource/?id=biblioref.referencesource.1645464
The objective of this literature review was to identify effective strategies for providing care to pregnant women in primary health care units to reduce neonatal and perinatal mortality in the municipality of Buri, SP, which does not have a maternity hospital in its territory. In this sense, high-quality prenatal care that considers equity in decision-making is of paramount importance. This work is part of a master's thesis defended in the Professional Master's Program in Public Health at the Institute of Health of the State Secretariat of Health of São Paulo. Forty-two systematic reviews were analyzed, which addressed the following categories of policy options: prenatal examinations; medications and treatments, community actions, prenatal modalities, continuous and postnatal care, preconception care, behavior change, and multicomponent approaches.]]> 1645464 Sun, 22 Feb 2026 00:00:00 UTC https://sites.bvsalud.org/pie/biblio/resource/?id=biblioref.referencesource.1636115
Discrimination and violence are critical barriers to equitable access to healthcare, affecting populations marked by racial, social, gender, and territorial inequalities. Understanding these vulnerabilities and their intersections is essential for guiding public policies that promote equity and inclusion in the healthcare system. Thus, the objective of the study was to identify effective strategies to address and prevent discrimination and violence in healthcare access for vulnerable populations, supporting the formulation and implementation of equitable public policies. To achieve this, a policy evidence synthesis was conducted following the recommendations of the Methodological Guideline of the Ministry of Health and the SUPPORT tools. Four main options were identified: (1) changes in care models, with cultural adaptations, community mobilization, telemedicine, and service reorganization; (2) communication and education, with professional training, psychoeducation, and culturally adapted information; (3) navigation, with support from professionals and informational materials to guide users; and (4) systemic interventions, such as income transfer programs and policies to expand coverage and retain professionals. The main results indicate an increase in access to and adherence to services, a reduction in inequalities, and an improvement in health outcomes. Considerations regarding the implementation and equity of the options were described in the systematic review texts.]]> 1636115 Sun, 16 Nov 2025 00:00:00 UTC https://sites.bvsalud.org/pie/biblio/resource/?id=biblioref.referencesource.1636926
Deliberative Dialogue (DD) is a method for sharing information, within the context of Knowledge Translation, that promotes the exchange between researchers, managers, civil society members, and other stakeholders on a specific topic. This tool enables the contextualization and integration of scientific evidence with tacit experiences and other forms of knowledge, aiming to review research content and integrate evidence with the participants' lived experiences. Its purpose is to clarify necessary actions, identify areas of uncertainty, and contextualize barriers and implementation facilitators, thus providing support for decision-making.The Deliberative Dialogue was held on August 8, 2025, from 08:00 AM to 12:00 PM, virtually, via the Zoom platform. There were 18 participants, representing managers (n=10), researchers (n=2), third-sector members (n=2), healthcare workers (n=2), and social control representatives (n=2). All participants were, in some way, involved in the theme of healthcare for vulnerable populations. In addition to the facilitator, eight observers were also present, who were members of the research team (n=6) and individuals interested in learning about the methodology used in the meeting (n=2). To promote a qualified and informed discussion, participants received the Evidence Synthesis: Addressing and Preventing Discrimination and Violence Against Vulnerable Populations in Healthcare Access in advance for analysis and reflection.The meeting, recorded with everyone's consent, began with individual introductions. Subsequently, the facilitator revisited the fundamentals of the methodology, ensuring a common level of understanding among those present, including those who did not participate in the initial training. The coordinator then presented the key findings of the Synthesis, highlighting the mapped options. The deliberative stage was conducted in three parts: Content Review, Implementation Considerations, and Equity Aspects Analysis.]]> 1636926 Wed, 19 Nov 2025 00:00:00 UTC https://sites.bvsalud.org/pie/biblio/resource/?id=biblioref.referencesource.1638576
Persistent social and economic inequalities in the Brazilian Border Strip (Faixa de Fronteira, FF) continue to hinder access to and performance of oral health indicators in the region. Since the inclusion of oral health teams in the Family Health Strategy (FHS) in 2000, Dentistry has expanded its role across all levels of the Unified Health System (SUS). This study aimed to compare oral health indicators from the FHS and Primary Health Care (PHC) between municipalities located in the FF and non-border municipalities belonging to the bordering states. This is an epidemiological longitudinal panel study that analyzed data from national information systems from 2015 to 2022, covering 1,722 municipalities classified as border or non-border. Three indicators were assessed: coverage of the first scheduled dental consultation; the ratio between completed treatments and first scheduled dental consultations; and the proportion of tooth extractions relative to individual preventive and restorative procedures performed by FHS teams. Comparisons were conducted using the Mann–Whitney test, with a 5% significance level. Statistical analyses were performed using IBM SPSS Statistics. Both groups of municipalities showed results below expected standards. Border municipalities demonstrated better performance in access to the first scheduled dental consultation and in the ratio between first consultations and completed treatments. Conversely, non-border municipalities performed relatively better in the indicator measuring the proportion of extractions relative to preventive and restorative procedures. However, statistically significant differences were observed only for the coverage of the first scheduled dental consultation (PHC) from 2015 to 2022; for the ratio between completed treatments and first consultations in 2016 and 2021; and for the proportion of extractions relative to preventive and restorative procedures from 2020 to 2022. In conclusion, there are measurable differences in oral health indicators between municipalities in the Border Strip and those located elsewhere in the bordering states. Nevertheless, further studies are needed to explore individual and contextual characteristics of these municipalities, the financing mechanisms supporting health services in the region, and opportunities for international cooperation.]]> 1638576 Fri, 12 Dec 2025 00:00:00 UTC https://sites.bvsalud.org/pie/biblio/resource/?id=biblioref.referencesource.1651065
THE PROBLEM - Stroke is recognized worldwide as the second leading cause of death and the third leading cause of combined death and disability. A global analysis indicated that between 2000 and 2016, the number of deaths from stroke increased by 19%. The incidence of stroke is increasing in young and middle-aged people (<55 years) globally, and unequal access to high-quality prevention, acute, and rehabilitation services is significant, especially in low- and middle-income countries. Clinical practice guideline recommendations - This rapid review identified 24 articles addressing recommendations from international clinical practice guidelines (Peru, Canada, China, United States, England, Spain, Germany, Australia, New Zealand, Japan, European countries, Korea, South Korea, Qatar). One guideline was developed by authors from several countries (Saudi Arabia, Australia, Belgium, Cameroon, Canada, China, USA, Netherlands, Norway, New Zealand, Switzerland, United Kingdom, Romania). The GPCs used evidence classification systems based on quality and confidence level. Below is a summary of the recommendations classified as "strong," based on scientific evidence and expert experience, regarding the diagnosis, prevention, treatment, and rehabilitation of stroke.]]> 1651065 Fri, 06 Mar 2026 00:00:00 UTC https://sites.bvsalud.org/pie/biblio/resource/?id=biblioref.referencesource.1621440
Method: A rapid review of the scientific literature was conducted on indicators that can be used to assess the health system's responsiveness to ischemic heart disease (IHD). Results: Forty-eight studies on IHD were included and analyzed, of which 27 addressed indicators for care coordination, diagnosis, surgical and interventional radiology procedures, treatment, education, health promotion, and rehabilitation. Additionally, 21 studies presented evidence from economic evaluations.]]> 1621440 Tue, 30 Sep 2025 00:00:00 UTC https://sites.bvsalud.org/pie/biblio/resource/?id=biblioref.referencesource.1586918
This summary aims to provide options based on scientific evidence, which consider the various dimensions involved in workers' health, covering effective practices arising from the HS and OS frameworks. Options for addressing the problem - This summary is intended for health managers who intend to implement the best available evidence for the health of Primary Care (PC) workers, using three options, formulated based on the available scientific evidence, to address the problem of burnout and potential burnout among health workers, and discussing the main barriers to implementing these options, as well as the equity implications involving the implementation of the options developed. Option 1. Establish a multidisciplinary program for the prevention and monitoring of health problems (burnout) for Primary Care workers: traditional health surveillance. This option was established along the lines of traditional surveillance of established health problems (burnout) and is affiliated with the Occupational Health approach: it is based on expanding notifications of health problems; train managers/coordinators in risk classification, and develop monitoring groups for workers with identified health problems. Option 2. Adopt a protocol for managing and monitoring Primary Care workers who return to work after being away due to a health problem (burnout): traditional health rehabilitation. This option was established along the lines of traditional rehabilitation aimed at health problems (burnout) that have already occurred, and is aligned with the occupational health approach: it is based on managing workers who return to work after medical leave, with assessment and monitoring of their work capacity. Option 3. Develop health practices focused on organizing work with the aim of strengthening workers: innovative practices in worker health. This option was established with the aim of improving the potential for strengthening at work in contrast to the potential for burnout among workers, and is aligned with the Worker Health approach: it is based on supporting the participation of work teams in defining proposals for improving work processes.]]> 1586918 Tue, 22 Apr 2025 00:00:00 UTC https://sites.bvsalud.org/pie/biblio/resource/?id=biblioref.referencesource.1608883
The problem - Ischemic heart disease (IHD) or coronary artery disease (CAD) are chronic conditions characterized by the accumulation of atherosclerotic plaques in the arteries that supply the heart. Clinical manifestations can range from acute to chronic. Insufficient oxygen supply due to obstruction in the coronary arteries results in cardiac ischemia and acute myocardial infarction (AMI). AMI can be divided into two categories: non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI). Modifiable risk factors account for 90% of AMI cases in men and 94% in women. These factors include smoking, a sedentary lifestyle, poor diet, and alcohol use, among others. Method - A rapid review of the scientific literature on clinical practice guideline recommendations for comprehensive care for people with IHD was conducted. Clinical Practice Guideline Recommendations - Thirteen international clinical practice guidelines (CGPs) (Canada, China, the United States, Japan, and European countries) were analyzed, using evidence classification systems based on quality and confidence. A summary of recommendations classified as "strong" regarding the diagnosis, prevention, treatment, and rehabilitation of IHD is presented.]]> 1608883 Wed, 10 Sep 2025 00:00:00 UTC https://sites.bvsalud.org/pie/biblio/resource/?id=biblioref.referencesource.1610190
The Problem - Stroke is the second leading cause of death and the third leading cause of death combined with disability worldwide. Between 2000 and 2016, stroke deaths increased by 19%, with a rising incidence among people under 55. Unequal access to health services exacerbates the situation, especially in low- and middle-income countries. Therefore, the use of monitoring and evaluation indicators is essential to monitor population health and improve the performance of health systems. Method - A rapid review of the scientific literature on monitoring and evaluation indicators of health system performance for comprehensive care for people with stroke was conducted. Results - Nine studies were included, presenting indicators related to stroke care coordination, diagnosis, treatment, education, promotion, and rehabilitation. Additionally, four studies present data on disability-adjusted life years.]]> 1610190 Thu, 29 Jan 2026 00:00:00 UTC